Cornelis J Lips

Title: Cornelis J Lips: Innovator in Peptide Technology

Introduction

Cornelis J Lips is a notable inventor based in The Hague, Netherlands. He has made significant contributions to the field of peptide technology, particularly in the development of oligopeptides and their applications in medicine. His work has implications for treating various health disorders, showcasing the importance of innovation in pharmaceutical science.

Latest Patents

Cornelis J Lips holds a patent for "Oligopeptides and intermediates and processes for their manufacture." This patent describes peptides that include specific amino acid sequences capable of forming intra- or inter-molecular disulfide bridges. The invention also covers derivatives with amidated terminal carboxy groups and acylated terminal amino groups, along with their salts. Furthermore, it includes DNA sequences coding for these peptides, microorganisms containing these sequences, and processes for their manufacture. The patent highlights the use of these peptide-amides in treating coronary circulation disorders and bone metabolism disorders. He has 1 patent to his name.

Career Highlights

Cornelis J Lips has had a distinguished career, primarily associated with Ciba-Geigy Corporation, a company known for its innovative contributions to the pharmaceutical and chemical industries. His work has been pivotal in advancing peptide research and its applications in medicine.

Collaborations

Throughout his career, Cornelis has collaborated with notable colleagues, including Hendrik S Jansz and Paul H Steenbergh. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field.

Conclusion

Cornelis J Lips stands out as an influential inventor in peptide technology, with a focus on developing innovative solutions for medical applications. His contributions continue to impact the pharmaceutical industry positively.